Back to B. Metzler seel. Sohn & Co. AG B. Metzler seel. Sohn & Co. AG

BBIOBBIO
Showing 8 of 18 quarters

Position history for B. Metzler seel. Sohn & Co. AGB. Metzler seel. Sohn & Co. AG's holdings in BRIDGEBIO PHARMA INC

B. Metzler seel. Sohn & Co. AG holds 17,506 shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.3M as of 2026-Q2. BBIO represents 0.0% of B. Metzler seel. Sohn & Co. AG's portfolio.

Current Value

$1.3M

Current Shares

17,506

Total Value Change

+$371,935

Total Shares Change

-19,097

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
17,506
0.0%
$1.3M0.0%$74.48
0
2026-Q1
Unchanged
17,506
0.0%
$1.3M0.0%$64.53
0
2025-Q4
Decreased
17,506
-29.3%
$1.3M0.0%$75.48
0
2025-Q3
Decreased
24,751
-32.4%
$1.3M0.0%$51.96
0
2025-Q2
Unchanged
36,603
0.0%
$1.6M0.0%$44.86
0
2025-Q1
Unchanged
36,603
0.0%
$1.3M0.0%$35.11
0
2024-Q4
Unchanged
36,603
0.0%
$1M0.0%$27.32
0
2024-Q3
Increased
36,603
+25.8%
$931,9120.0%$24.94
31

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used